Ramesh K. Ganju - Publications

Affiliations: 
Molecular, Cellular and Developmental Biology Ohio State University, Columbus, Columbus, OH 
Area:
Molecular Biology

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Holter JC, Chang CW, Avendano A, Garg AA, Verma AK, Charan M, Ahirwar DK, Ganju RK, Song JW. Fibroblast-derived CXCL12 increases vascular permeability in a 3-D microfluidic model independent of extracellular matrix contractility. Frontiers in Bioengineering and Biotechnology. 10: 888431. PMID 36118583 DOI: 10.3389/fbioe.2022.888431  0.365
2022 Ahirwar DK, Peng B, Charan M, Misri S, Mishra S, Kaul K, Sassi S, Gadepalli VS, Siddiqui J, Miles WO, Ganju RK. Slit2/Robo1 signaling inhibits small cell lung cancer by targeting β-catenin signaling in tumor cells and macrophages. Molecular Oncology. PMID 35838343 DOI: 10.1002/1878-0261.13289  0.375
2022 Datta J, Willingham N, Manouchehri JM, Schnell P, Sheth M, David JJ, Kassem M, Wilson TA, Radomska HS, Coss CC, Bennett CE, Ganju RK, Sardesai SD, Lustberg M, Ramaswamy B, et al. Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer. Frontiers in Oncology. 12: 857590. PMID 35574319 DOI: 10.3389/fonc.2022.857590  0.4
2022 Mishra S, Ahirwar DK, Srivastava AK, Tripathi PP, Ganju RK. Editorial: Inflammation and Myeloid Cells in Cancer Progression and Metastasis. Frontiers in Cell and Developmental Biology. 10: 913595. PMID 35573674 DOI: 10.3389/fcell.2022.913595  0.342
2022 Manouchehri JM, Datta J, Willingham N, Wesolowski R, Stover D, Ganju RK, Carson WE, Ramaswamy B, Cherian MA. Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer. Frontiers in Oncology. 12: 855032. PMID 35515134 DOI: 10.3389/fonc.2022.855032  0.378
2022 Mishra S, Charan M, Shukla RK, Agarwal P, Misri S, Verma AK, Ahirwar DK, Siddiqui J, Kaul K, Sahu N, Vyas K, Garg AA, Khan A, Miles WO, Song JW, ... ... Ganju RK, et al. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment. Journal of Experimental & Clinical Cancer Research : Cr. 41: 54. PMID 35135586 DOI: 10.1186/s13046-021-02221-0  0.418
2021 Abrams DI, Velasco G, Twelves C, Ganju RK, Bar-Sela G. Cancer Treatment: Preclinical & Clinical. Journal of the National Cancer Institute. Monographs. 2021: 107-113. PMID 34850894 DOI: 10.1093/jncimonographs/lgab010  0.362
2021 Jones TH, Kaul K, Garg AA, Song JW, Ganju RK, Subramaniam VV. Directional Migration of Breast Cancer Cells Hindered by Induced Electric Fields May Be Due to Accompanying Alteration of Metabolic Activity. Bioelectricity. 3: 92-100. PMID 34476380 DOI: 10.1089/bioe.2020.0048  0.422
2021 Ahirwar DK, Charan M, Mishra S, Verma AK, Shilo K, Ramaswamy B, Ganju RK. Slit2 inhibits breast cancer metastasis by activating M1-like phagocytic and anti-fibrotic macrophages. Cancer Research. PMID 34400395 DOI: 10.1158/0008-5472.CAN-20-3909  0.384
2021 Wilkie T, Verma AK, Zhao H, Charan M, Ahirwar DK, Kant S, Pancholi V, Mishra S, Ganju RK. Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4. Molecular Oncology. PMID 33969603 DOI: 10.1002/1878-0261.12975  0.422
2020 Hussain S, Peng B, Cherian M, Song JW, Ahirwar DK, Ganju RK. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases. Frontiers in Immunology. 11: 598532. PMID 33414786 DOI: 10.3389/fimmu.2020.598532  0.336
2020 Mal R, Magner A, David J, Datta J, Vallabhaneni M, Kassem M, Manouchehri J, Willingham N, Stover D, Vandeusen J, Sardesai S, Williams N, Wesolowski R, Lustberg M, Ganju RK, et al. Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor. Frontiers in Oncology. 10: 587386. PMID 33194742 DOI: 10.3389/fonc.2020.587386  0.37
2020 Charan M, Das S, Mishra S, Chatterjee N, Varikuti S, Kaul K, Misri S, Ahirwar DK, Satoskar AR, Ganju RK. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer. Cell Death & Disease. 11: 774. PMID 32943608 DOI: 10.1038/S41419-020-02992-Y  0.54
2020 Charan M, Verma AK, Hussain S, Misri S, Mishra S, Majumder S, Ramaswamy B, Ahirwar D, Ganju RK. Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer. International Journal of Molecular Sciences. 21. PMID 32824813 DOI: 10.3390/Ijms21165936  0.465
2020 Varikuti S, Singh B, Volpedo G, Ahirwar DK, Jha BK, Saljoughian N, Viana AG, Verma C, Hamza O, Halsey G, Holcomb EA, Maryala RJ, Oghumu S, Ganju RK, Satoskar AR. Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells. British Journal of Cancer. PMID 32025027 DOI: 10.1096/Fasebj.2020.34.S1.06611  0.54
2020 Ahirwar DK, Ganju RK, Mishra S, Shilo K, Kaul K. Abstract P5-04-14: Recombinant Slit2 suppresses breast cancer metastasis by activating anti-tumor macrophages Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-04-14  0.551
2020 Cherian M, Datta J, Kassem M, Willingham N, Manouchehri J, David J, Sheth M, Magner A, Mal R, Morgan E, VanDeusen J, Sardesai S, Williams N, Stover D, Lustberg M, ... ... Ganju R, et al. Abstract 5158: Estrogen receptor β agonists: A novel therapeutic strategy for breast cancer Cancer Research. 80: 5158-5158. DOI: 10.1158/1538-7445.Am2020-5158  0.541
2019 Garg AA, Jones TH, Moss SM, Mishra S, Kaul K, Ahirwar DK, Ferree J, Kumar P, Subramaniam D, Ganju RK, Subramaniam VV, Song JW. Electromagnetic fields alter the motility of metastatic breast cancer cells. Communications Biology. 2: 303. PMID 31925108 DOI: 10.1038/s42003-019-0550-z  0.456
2019 Garg AA, Jones TH, Moss SM, Mishra S, Kaul K, Ahirwar DK, Ferree J, Kumar P, Subramaniam D, Ganju RK, Subramaniam VV, Song JW. Electromagnetic fields alter the motility of metastatic breast cancer cells. Communications Biology. 2: 303. PMID 31428691 DOI: 10.1038/s42003-019-0550-z  0.456
2019 Das S, Kaul K, Mishra S, Charan M, Ganju RK. Cannabinoid Signaling in Cancer. Advances in Experimental Medicine and Biology. 1162: 51-61. PMID 31332734 DOI: 10.1007/978-3-030-21737-2_4  0.466
2019 Basree MM, Shinde N, Koivisto C, Cuitino M, Kladney R, Zhang J, Stephens J, Palettas M, Zhang A, Kim HK, Acero-Bedoya S, Trimboli A, Stover DG, Ludwig T, Ganju R, et al. Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer. Breast Cancer Research : Bcr. 21: 80. PMID 31315645 DOI: 10.1186/S13058-019-1163-7  0.46
2019 Chatterjee N, Das S, Ahiwar D, Mishra S, Kaul K, Ganju R. Abstract P2-06-24: Cannabinoid receptors agonist induces lysosome-mediated cell death in TNBC Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-06-24  0.551
2019 Mishra S, Ahiwar D, Shukla R, Chatterjee N, Ganju R. Abstract P2-03-05: S100A7 enhances triple negative breast cancer growth and metastasis by cross-talk with resistin Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-03-05  0.586
2019 Kaul K, Ahirwar D, Benej M, Denko N, Ganju R. Abstract P2-02-08: Slit2 induced anti-tumor activity may be mediated through metabolism driven immunomodulation Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-02-08  0.45
2019 Ahirwar DK, Chatterjee N, Mishra S, Shilo K, Ganju R. Abstract 4561: Slit2 inhibits breast cancer growth and metastasis by activating anti-tumor immune response Cancer Research. 79: 4561-4561. DOI: 10.1158/1538-7445.Am2019-4561  0.545
2019 Chatterjee N, Das S, Ahirwar DK, Mishra S, Ganju R. Abstract 2018: Cannabinoid receptor 2 agonist JWH-015 inhibits growth and metastasis of triple negative breast cancers through regulation of autophagy mechanism Cancer Research. 79: 2018-2018. DOI: 10.1158/1538-7445.Am2019-2018  0.557
2019 Sassi SE, Ahirwar D, Ganju RK. Abstract 121: S100A9 inhibitor Tasquinimod: A novel strategy to inhibit small cell lung cancer progression and metastasis Cancer Research. 79: 121-121. DOI: 10.1158/1538-7445.Am2019-121  0.511
2019 Das S, Chatterjee N, Ahirwar DK, Mishra S, Varikuti S, Kaul K, Satoskar AR, Ganju RK. Macrophage migration inhibitory factor (MIF):A novel therapeutic target against aggressive breast cancer The Faseb Journal. 33. DOI: 10.1096/fasebj.2019.33.1_supplement.674.3  0.37
2018 Yeung DA, Shanker N, Sohail A, Weiss BA, Wang C, Wellmerling J, Das S, Ganju RK, Miller JLC, Herr AB, Fridman R, Agarwal G. Clustering, Spatial Distribution and Phosphorylation of Discoidin Domain Receptors 1 and 2 in Response to Soluble Collagen Type I. Journal of Molecular Biology. PMID 30458172 DOI: 10.1016/J.Jmb.2018.11.015  0.303
2018 Elbaz M, Ahirwar D, Xiaoli Z, Zhou X, Lustberg M, Nasser MW, Shilo K, Ganju RK. TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer. Oncotarget. 9: 33459-33470. PMID 30323891 DOI: 10.18632/Oncotarget.9663  0.502
2018 Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuitiño MC, Kladney RD, Varikuti S, Kaul K, Satoskar AR, Ramaswamy B, Zhang X, Ostrowski MC, Leone G, Ganju RK. Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene. PMID 29720724 DOI: 10.1038/S41388-018-0263-7  0.531
2018 Wilkie T, Zhao H, Nasser M, Ahirwar D, Mishra S, Satoskar A, Pancholi V, Ganju R. Abstract P1-01-19: The role of S100A7 in microbiota mediated inflammation and breast cancer progression Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-01-19  0.54
2018 Das S, Chatterjee N, Mishra S, Ahirwar DK, Varikuti S, Kaul K, Shukla RK, Satoskar AR, Ganju RK. Abstract 5870: CPSI-1306: A novel macrophage migration inhibitory factor inhibitor against aggressive breast cancer Cancer Research. 78: 5870-5870. DOI: 10.1158/1538-7445.Am2018-5870  0.566
2017 Varikuti S, Oghumu S, Elbaz M, Volpedo G, Ahirwar DK, Alarcon PC, Sperling RH, Moretti E, Pioso MS, Kimble J, Nasser MW, Ganju RK, Terrazas C, Satoskar AR. STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade. Oncoimmunology. 6: e1361088. PMID 29147627 DOI: 10.1080/2162402X.2017.1361088  0.524
2017 Ahirwar D, Shehab R, Mishra S, Shilo K, Ganju R. Abstract P6-01-03: N-terminus Slit2 suppresses breast cancer metastasis by inhibiting tumor associated macrophages Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P6-01-03  0.492
2016 Mishra S, Ahirwar DK, Ganju RK. Psoriasin (S100A7): a novel mediator of angiogenesis. The British Journal of Dermatology. 175: 1141-1142. PMID 27996128 DOI: 10.1111/Bjd.15141  0.332
2016 Sarkar C, Ganju RK, Pompili VJ, Chakroborty D. Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesis. Angiogenesis. PMID 27853962 DOI: 10.1007/S10456-016-9531-8  0.311
2016 Elbaz M, Ahirwar D, Xiaoli Z, Zhou X, Lustberg M, Nasser MW, Shilo K, Ganju RK. TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer. Oncotarget. PMID 27248470 DOI: 10.18632/oncotarget.9663  0.41
2016 Elbaz M, Ahirwar D, Ravi J, Nasser MW, Ganju RK. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer. Oncotarget. PMID 27213582 DOI: 10.18632/Oncotarget.9408  0.552
2016 Nasser MW, Ahirwar DK, Ganju RK. RAGE: A novel target for breast cancer growth and metastasis. Oncoscience. 3: 52-3. PMID 27014721 DOI: 10.18632/oncoscience.294  0.382
2016 Ravi J, Elbaz M, Wani NA, Nasser MW, Ganju RK. Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway. Molecular Carcinogenesis. PMID 26741322 DOI: 10.1002/Mc.22451  0.467
2016 Ahirwar DK, Nasser MW, Elbaz M, Shilo K, Ganju R. Abstract 916: Slit2 inhibits breast cancer growth and metastasis by modulating tumor microenvironment Cancer Research. 76: 916-916. DOI: 10.1158/1538-7445.Am2016-916  0.57
2016 Elbaz M, Nasser M, Ravi J, Ahirwar D, Ganju R. Abstract 729: Novel role of CB2R in tuning breast tumor microenvironment, EGF/EGFR and IGF-I/IGF-IR pathways Cancer Research. 76: 729-729. DOI: 10.1158/1538-7445.Am2016-729  0.57
2015 Zhao H, Ahirwar DK, Oghumu S, Wilkie T, Powell CA, Satoskar AR, Li DY, Ganju RK. Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis. Molecular Oncology. PMID 26778715 DOI: 10.1016/J.Molonc.2015.10.007  0.536
2015 Zhao H, Wilkie T, Deol Y, Sneh A, Ganju A, Basree M, Nasser MW, Ganju RK. Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Molecular Cancer. 14: 195. PMID 26573004 DOI: 10.1186/S12943-015-0451-9  0.722
2015 Nasser MW, Elbaz M, Ahirwar DK, Ganju RK. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins. Cancer Letters. 365: 11-22. PMID 25963887 DOI: 10.1016/J.Canlet.2015.05.002  0.477
2015 Powell CA, Nasser MW, Zhao H, Wochna JC, Zhang X, Shapiro C, Shilo K, Ganju RK. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability. Oncotarget. 6: 6373-85. PMID 25779666 DOI: 10.18632/Oncotarget.3442  0.566
2015 Elbaz M, Nasser MW, Ravi J, Wani NA, Ahirwar DK, Zhao H, Oghumu S, Satoskar AR, Shilo K, Carson WE, Ganju RK. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer. Molecular Oncology. 9: 906-19. PMID 25660577 DOI: 10.1016/J.Molonc.2014.12.010  0.58
2015 Zhao H, Wilkie T, Deol Y, Sneh A, Ganju A, Basree M, Nasser MW, Ganju RK. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Molecular Cancer. 14: 11. PMID 25622979 DOI: 10.1186/S12943-014-0275-Z  0.759
2015 Nasser MW, Wani NA, Ahirwar DK, Powell CA, Ravi J, Elbaz M, Zhao H, Padilla L, Zhang X, Shilo K, Ostrowski M, Shapiro C, Carson WE, Ganju RK. RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. Cancer Research. 75: 974-85. PMID 25572331 DOI: 10.1158/0008-5472.Can-14-2161  0.575
2015 Zhao H, Nasser MW, Wilkie T, Ganju RK. Abstract P4-04-07: Breast cancer tissue context determines whether inflammation with bacterial/psoriasin signature is pro- or anti-carcinogenesis Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-04-07  0.535
2015 Powell CA, Nasser MW, Wochna JC, Shilo K, Zhang X, Ganju RK. Abstract P1-07-35: Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-07-35  0.429
2015 Elbaz MM, Nasser MW, Zhao H, Ganju RK. Abstract 3487: A novel role of transient receptor potential vanilloid type 2 (TRPV2) for augmentation of chemotherapeutic drug efficacy in triple-negative breast cancer Cancer Research. 75: 3487-3487. DOI: 10.1158/1538-7445.Am2015-3487  0.523
2015 Nasser MW, Wani NA, Ravi J, Amponsah GA, Ahirwar DK, Powell CA, Elbaz M, Zhao H, Shilo K, Ganju RK. Abstract 3363: RAGE/S100A7/Stat3-axis enhances breast cancer growth and metastasis via modulating tumor microenvironment Cancer Research. 75: 3363-3363. DOI: 10.1158/1538-7445.Am2015-3363  0.583
2014 Chakravarti B, Ravi J, Ganju RK. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 5: 5852-72. PMID 25115386 DOI: 10.18632/Oncotarget.2233  0.44
2014 Wani N, Nasser MW, Ahirwar DK, Zhao H, Miao Z, Shilo K, Ganju RK. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment. Breast Cancer Research : Bcr. 16: R54. PMID 24886617 DOI: 10.1186/Bcr3665  0.422
2014 Ravi J, Sneh A, Shilo K, Nasser MW, Ganju RK. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway. Oncotarget. 5: 2475-86. PMID 24811863 DOI: 10.18632/Oncotarget.1723  0.409
2014 Oghumu S, Varikuti S, Terrazas C, Kotov D, Nasser MW, Powell CA, Ganju RK, Satoskar AR. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology. 143: 109-19. PMID 24679047 DOI: 10.1111/Imm.12293  0.493
2014 Lu Y, Wu Y, Feng X, Shen R, Wang JH, Fallahi M, Li W, Yang C, Hankey W, Zhao W, Ganju RK, Li MO, Cleveland JL, Zou X. CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis. The Journal of Clinical Investigation. 124: 1672-84. PMID 24614102 DOI: 10.1172/Jci63139  0.381
2014 Zhao H, Anand AR, Ganju RK. Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia. Journal of Immunology (Baltimore, Md. : 1950). 192: 385-93. PMID 24272999 DOI: 10.4049/Jimmunol.1302021  0.356
2014 Wang B, Hsu SH, Wang X, Kutay H, Bid HK, Yu J, Ganju RK, Jacob ST, Yuneva M, Ghoshal K. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. Hepatology (Baltimore, Md.). 59: 555-66. PMID 24038073 DOI: 10.1002/Hep.26712  0.322
2014 Ravi J, Sneh A, Shilo K, Nasser M, Ganju R. Abstract 3324: The endocannabinoid system inhibits non-small cell lung cancer tumorigenesis by modulating the EGF/EGFR pathway Cancer Research. 74: 3324-3324. DOI: 10.1158/1538-7445.Am2014-3324  0.443
2013 Sneh A, Deol YS, Ganju A, Shilo K, Rosol TJ, Nasser MW, Ganju RK. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling. Breast Cancer Research and Treatment. 138: 727-39. PMID 23535840 DOI: 10.1007/S10549-013-2491-4  0.776
2013 Anand AR, Zhao H, Nagaraja T, Robinson LA, Ganju RK. N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. Retrovirology. 10: 2. PMID 23294842 DOI: 10.1186/1742-4690-10-2  0.338
2013 Nagaraja T, Chen L, Balasubramanian A, Groopman JE, Ghoshal K, Jacob ST, Leask A, Brigstock DR, Anand AR, Ganju RK. p38 MAP kinase mediates CTGF expression in Huh7.5-FL cells. Plos One. DOI: 10.1371/Journal.Pone.0046526.G007  0.332
2012 Nagaraja T, Anand AR, Zhao H, Ganju RK. The adaptor protein SLP-76 regulates HIV-1 release and cell-to-cell transmission in T cells. Journal of Immunology (Baltimore, Md. : 1950). 188: 2769-77. PMID 22323535 DOI: 10.4049/Jimmunol.1102106  0.332
2012 Talebian F, Liu JQ, Liu Z, Khattabi M, He Y, Ganju R, Bai XF. Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions. Plos One. 7: e31442. PMID 22319630 DOI: 10.1371/Journal.Pone.0031442  0.395
2012 Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH, Ganju RK. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Research. 72: 604-15. PMID 22158945 DOI: 10.1158/0008-5472.Can-11-0669  0.786
2012 Yadwinder DS, Nasser MW, Ganju RK. Abstract 480: Psoriasin (S100A7) regulates epidermal growth factor signaling and actin polymerization in estrogen receptor positive breast cancer cells Cancer Research. 72: 480-480. DOI: 10.1158/1538-7445.Am2012-480  0.581
2012 Saleem M, Siddique HR, Ganju R, Mishra SK, Aburatani H. Abstract 3917: Regulatory role of ROBO-1, a novel tumor suppressor on Androgen receptor and Wnt signaling during castration-resistant prostate cancer development: A novel molecular target for gene therapy Cancer Research. 72: 3917-3917. DOI: 10.1158/1538-7445.Am2012-3917  0.402
2012 Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Shilo K, Wolf R, Yuspa SH, Ganju RK. Abstract 388: mS100a7a15 enhances mammary tumor growth and metastasis by recruiting tumor associated macrophages Cancer Research. 72: 388-388. DOI: 10.1158/1538-7445.Am2012-388  0.776
2011 Deol YS, Nasser MW, Yu L, Zou X, Ganju RK. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells. The Journal of Biological Chemistry. 286: 44845-54. PMID 22016394 DOI: 10.1074/Jbc.M111.225466  0.787
2011 Nasser MW, Qamri Z, Deol YS, Smith D, Shilo K, Zou X, Ganju RK. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. Plos One. 6: e23901. PMID 21915267 DOI: 10.1371/Journal.Pone.0023901  0.762
2011 Anand AR, Tirumuru Nagaraja, Ganju RK. A novel role for Slit2/Robo1 axis in modulating HIV-1 replication in T cells. Aids (London, England). 25: 2105-11. PMID 21857494 DOI: 10.1097/Qad.0B013E32834Bab86  0.316
2011 Feng X, Wu Z, Wu Y, Hankey W, Prior TW, Li L, Ganju RK, Shen R, Zou X. Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells. Molecular and Cellular Biology. 31: 3457-71. PMID 21670150 DOI: 10.1128/Mcb.05523-11  0.561
2011 Tamama K, Kawasaki H, Kerpedjieva SS, Guan J, Ganju RK, Sen CK. Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. Journal of Cellular Biochemistry. 112: 804-17. PMID 21328454 DOI: 10.1002/Jcb.22961  0.323
2011 Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, Zou X, Groopman JE, Ganju RK. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prevention Research (Philadelphia, Pa.). 4: 65-75. PMID 21097714 DOI: 10.1158/1940-6207.Capr-10-0181  0.465
2011 Nasser MW, Qamri Z, Deol YS, Leone G, Zou X, Wolf R, Yuspa SH, Ganju RK. Abstract 403: Overexpression of S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways Cancer Research. 71: 403-403. DOI: 10.1158/1538-7445.Am2011-403  0.782
2011 Deol YS, Nasser MW, Ganju R. Abstract 1024: Tumor suppressive effects of S100A7 are mediated through β-catenin/TCF4 pathway in ERα positive breast cancer Cancer Research. 71: 1024-1024. DOI: 10.1158/1538-7445.Am2011-1024  0.77
2010 Wu Y, Feng X, Jin Y, Wu Z, Hankey W, Paisie C, Li L, Liu F, Barsky SH, Zhang W, Ganju R, Zou X. A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation. Cancer Prevention Research (Philadelphia, Pa.). 3: 818-28. PMID 20587702 DOI: 10.1158/1940-6207.Capr-09-0213  0.464
2010 Qamri Z, Nasser MW, Abdussamad A, Lill N, Ganju RK. Abstract 5277: S100A7 modulates EGFR signaling in estrogen receptor negative breast cancer cell lines Cancer Research. 70: 5277-5277. DOI: 10.1158/1538-7445.Am10-5277  0.554
2010 Nasser MW, Qamri Z, Adel M, Abdussamad A, Leone G, Yuspa SH, Ganju RK. Abstract 3949: S100A7 modulates growth factor-mediated signaling in estrogen receptor negative breast cancer Cancer Research. 70: 3949-3949. DOI: 10.1158/1538-7445.Am10-3949  0.591
2010 Yadwinder DS, Nasser MW, Ganju RK. Abstract 2308: S100A7 as a novel mediator of mesenchymal to epithelial transition in ERα+ breast cancer Cancer Research. 70: 2308-2308. DOI: 10.1158/1538-7445.Am10-2308  0.561
2009 Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, Ganju RK. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Molecular Cancer Therapeutics. 8: 3117-29. PMID 19887554 DOI: 10.1158/1535-7163.Mct-09-0448  0.57
2009 Anand AR, Prasad A, Bradley RR, Deol YS, Nagaraja T, Ren X, Terwilliger EF, Ganju RK. HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1. Blood. 114: 3588-600. PMID 19700666 DOI: 10.1182/Blood-2009-02-206342  0.692
2009 Anand AR, Bradley R, Ganju RK. LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway. Molecular Immunology. 46: 962-8. PMID 18954908 DOI: 10.1016/J.Molimm.2008.09.022  0.366
2008 Desai AG, Qazi GN, Ganju RK, El-Tamer M, Singh J, Saxena AK, Bedi YS, Taneja SC, Bhat HK. Medicinal plants and cancer chemoprevention. Current Drug Metabolism. 9: 581-91. PMID 18781909 DOI: 10.2174/138920008785821657  0.329
2008 Prasad A, Paruchuri V, Preet A, Latif F, Ganju RK. Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells. The Journal of Biological Chemistry. 283: 26624-33. PMID 18611862 DOI: 10.1074/Jbc.M800679200  0.527
2008 Mense SM, Hei TK, Ganju RK, Bhat HK. Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environmental Health Perspectives. 116: 426-33. PMID 18414622 DOI: 10.1289/Ehp.10538  0.462
2008 Anand AR, Cucchiarini M, Terwilliger EF, Ganju RK. The tyrosine kinase Pyk2 mediates lipopolysaccharide-induced IL-8 expression in human endothelial cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5636-44. PMID 18390748 DOI: 10.4049/Jimmunol.180.8.5636  0.322
2008 Paruchuri V, Prasad A, McHugh K, Bhat HK, Polyak K, Ganju RK. S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation. Plos One. 3: e1741. PMID 18320059 DOI: 10.1371/Journal.Pone.0001741  0.565
2008 Gupta A, Guerin-Peyrou TG, Sharma GG, Park C, Agarwal M, Ganju RK, Pandita S, Choi K, Sukumar S, Pandita RK, Ludwig T, Pandita TK. The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis. Molecular and Cellular Biology. 28: 397-409. PMID 17967868 DOI: 10.1128/Mcb.01045-07  0.329
2008 Preet A, Ganju RK, Groopman JE. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene. 27: 339-346. PMID 17621270 DOI: 10.1038/Sj.Onc.1210641  0.49
2007 Prasad A, Qamri Z, Wu J, Ganju RK. Pivotal Advance: Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells Journal of Leukocyte Biology. 82: 465-476. PMID 17565045 DOI: 10.1189/Jlb.1106678  0.43
2006 Balasubramanian A, Ganju RK, Groopman JE. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. The Journal of Infectious Diseases. 194: 670-81. PMID 16897667 DOI: 10.1086/505708  0.353
2006 Lane HC, Anand AR, Ganju RK. Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis. International Immunology. 18: 1315-25. PMID 16798838 DOI: 10.1093/Intimm/Dxl064  0.414
2006 Anand AR, Ganju RK. HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. The Journal of Biological Chemistry. 281: 12289-99. PMID 16524887 DOI: 10.1074/Jbc.M511786200  0.334
2006 Ghosh S, Preet A, Groopman JE, Ganju RK. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Molecular Immunology. 43: 2169-79. PMID 16503355 DOI: 10.1016/J.Molimm.2006.01.005  0.402
2006 Anand AR, Ganju RK. The Tyrosine Kinase, Pyk2/RAFTK, Mediates LPS-Induced IL-8 and MCP-1 Expression in Human Endothelial Cells. Blood. 108: 1820-1820. DOI: 10.1182/Blood.V108.11.1820.1820  0.349
2006 Bailuguttu AP, Ganju RK. Modulation of Dendritic Cell Chemotaxis by HIV-gp120. Blood. 108: 1252-1252. DOI: 10.1182/Blood.V108.11.1252.1252  0.345
2004 Wang JF, Liu ZY, Anand AR, Zhang X, Brown LF, Dezube BJ, Gill P, Ganju RK. Alpha-chemokine-mediated signal transduction in human Kaposi's sarcoma spindle cells. Biochimica Et Biophysica Acta. 1691: 129-39. PMID 15110993 DOI: 10.1016/J.Bbamcr.2004.01.002  0.447
2004 Fernandis AZ, Prasad A, Band H, Klösel R, Ganju RK. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene. 23: 157-67. PMID 14712221 DOI: 10.1038/Sj.Onc.1206910  0.578
2004 Prasad A, Fernandis AZ, Rao Y, Ganju RK. Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. The Journal of Biological Chemistry. 279: 9115-24. PMID 14645233 DOI: 10.1074/Jbc.M308083200  0.58
2004 Balasubramanian A, Ganju RK, Groopman JE. HCV and HIV Envelope Proteins Co-Operatively Induce Fas-Mediated Apoptosis Via a Novel Stat1 Signaling Pathway. Blood. 104: 604-604. DOI: 10.1182/Blood.V104.11.604.604  0.321
2004 Anand AR, Ganju RK. Akt Regulates the Activation-Induced Apoptosis of T Cells Mediated by HIV-1 gp120. Blood. 104: 3109-3109. DOI: 10.1182/Blood.V104.11.3109.3109  0.394
2004 Ghosh S, Ganju RK, Groopman JE. Cannabinoids Inhibit the CXCL12-Induced Migration of T Lymphocytes. Blood. 104: 2667-2667. DOI: 10.1182/Blood.V104.11.2667.2667  0.379
2004 Lane HC, Anand AR, Fernandis AZ, Ganju RK. Cbl Regulates CXCR4-Mediated Chemotaxis and CXCR4 Receptor Internalization. Blood. 104: 2658-2658. DOI: 10.1182/Blood.V104.11.2658.2658  0.444
2003 Munshi N, Balasubramanian A, Koziel M, Ganju RK, Groopman JE. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. The Journal of Infectious Diseases. 188: 1192-204. PMID 14551890 DOI: 10.1086/378643  0.308
2003 Balasubramanian A, Ganju RK, Groopman JE. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. The Journal of Biological Chemistry. 278: 35755-66. PMID 12824191 DOI: 10.1074/Jbc.M302889200  0.312
2003 Fernandis AZ, Cherla RP, Ganju RK. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45. The Journal of Biological Chemistry. 278: 9536-43. PMID 12519755 DOI: 10.1074/Jbc.M211803200  0.397
2002 Munshi N, Fernandis AZ, Cherla RP, Park IW, Ganju RK. Lipopolysaccharide-induced apoptosis of endothelial cells and its inhibition by vascular endothelial growth factor. Journal of Immunology (Baltimore, Md. : 1950). 168: 5860-6. PMID 12023390 DOI: 10.4049/Jimmunol.168.11.5860  0.334
2002 Fernandis AZ, Cherla RP, Chernock RD, Ganju RK. CXCR4/CCR5 down-modulation and chemotaxis are regulated by the proteasome pathway. The Journal of Biological Chemistry. 277: 18111-7. PMID 11877445 DOI: 10.1074/Jbc.M200750200  0.386
2001 Fernandis AZ, Ganju RK. Slit: a roadblock for chemotaxis. Science Signaling. 2001. PMID 11752663 DOI: 10.1126/Stke.2001.91.Pe1  0.358
2001 Park IW, Ullrich CK, Schoenberger E, Ganju RK, Groopman JE. HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. Journal of Immunology (Baltimore, Md. : 1950). 167: 2766-71. PMID 11509621 DOI: 10.4049/Jimmunol.167.5.2766  0.331
2001 Cherla RP, Ganju RK. Stromal Cell-Derived Factor 1α-Induced Chemotaxis in T Cells Is Mediated by Nitric Oxide Signaling Pathways Journal of Immunology. 166: 3067-3074. PMID 11207257 DOI: 10.4049/Jimmunol.166.5.3067  0.422
2001 Chernock RD, Cherla RP, Ganju RK. SHP2 and cbl participate in α-chemokine receptor CXCR4–mediated signaling pathways Blood. 97: 608-615. PMID 11157475 DOI: 10.1182/Blood.V97.3.608  0.412
2000 Ganju RK, Brubaker SA, Chernock RD, Avraham S, Groopman JE. β-Chemokine Receptor CCR5 Signals through SHP1, SHP2, and Syk Journal of Biological Chemistry. 275: 17263-17268. PMID 10747947 DOI: 10.1074/Jbc.M000689200  0.427
2000 Munshi N, Groopman JE, Gill PS, Ganju RK. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. Journal of Immunology (Baltimore, Md. : 1950). 164: 1169-74. PMID 10640727 DOI: 10.4049/Jimmunol.164.3.1169  0.395
2000 Ullrich CK, Groopman JE, Ganju RK. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases Blood. 96: 1438-1442. DOI: 10.1182/Blood.V96.4.1438  0.348
1999 Skobe M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K, Detmar M. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. The Journal of Investigative Dermatology. 113: 1047-53. PMID 10594750 DOI: 10.1046/J.1523-1747.1999.00798.X  0.341
1999 Munshi N, Ganju RK, Avraham S, Mesri EA, Groopman JE. Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2. The Journal of Biological Chemistry. 274: 31863-7. PMID 10542211 DOI: 10.1074/Jbc.274.45.31863  0.387
1998 Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W, Groopman JE. The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways Journal of Biological Chemistry. 273: 23169-23175. PMID 9722546 DOI: 10.1074/Jbc.273.36.23169  0.374
1998 Ganju RK, Munshi N, Nair BC, Liu Z, Gill P, Groopman JE. Human Immunodeficiency Virus Tat Modulates the Flk-1/KDR Receptor, Mitogen-Activated Protein Kinases, and Components of Focal Adhesion in Kaposi’s Sarcoma Cells Journal of Virology. 72: 6131-6137. PMID 9621077 DOI: 10.1128/Jvi.72.7.6131-6137.1998  0.41
1998 Ganju RK, Dutt P, Wu L, Newman W, Avraham H, Avraham S, Groopman JE. β-Chemokine Receptor CCR5 Signals Via the Novel Tyrosine Kinase RAFTK Blood. 91: 791-797. DOI: 10.1182/Blood.V91.3.791.791_791_797  0.392
1998 Hatch WC, Ganju RK, Hiregowdara D, Avraham S, Groopman JE. The Related Adhesion Focal Tyrosine Kinase (RAFTK) Is Tyrosine Phosphorylated and Participates in Colony-Stimulating Factor-1/Macrophage Colony-Stimulating Factor Signaling in Monocyte-Macrophages Blood. 91: 3967-3973. DOI: 10.1182/Blood.V91.10.3967.3967_3967_3973  0.368
1997 Liu ZY, Ganju RK, Wang JF, Ona MA, Hatch WC, Zheng T, Avraham S, Gill P, Groopman JE. Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. Journal of Clinical Investigation. 99: 1798-1804. PMID 9120025 DOI: 10.1172/Jci119344  0.431
1997 Ganju RK, Hatch WC, Avraham H, Ona MA, Druker B, Avraham S, Groopman JE. RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes. The Journal of Experimental Medicine. 185: 1055-63. PMID 9091579 DOI: 10.1084/Jem.185.6.1055  0.377
1997 Wang J, Ganju RK, Liu Z, Avraham H, Avraham S, Groopman JE. Signal Transduction in Human Hematopoietic Cells by Vascular Endothelial Growth Factor Related Protein, a Novel Ligand for the FLT4 Receptor Blood. 90: 3507-3515. DOI: 10.1182/Blood.V90.9.3507  0.433
1997 Liu Z, Ganju RK, Wang J, Schweitzer K, Weksler B, Avraham S, Groopman JE. Characterization of Signal Transduction Pathways in Human Bone Marrow Endothelial Cells Blood. 90: 2253-2259. DOI: 10.1182/Blood.V90.6.2253.2253_2253_2259  0.398
1994 Ganju RK, Sunday M, Tsarwhas DG, Card A, Shipp MA. CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation. Journal of Clinical Investigation. 94: 1784-1791. PMID 7962523 DOI: 10.1172/Jci117526  0.325
Show low-probability matches.